MaaT Pharma S.A.

MAAT.PA · PAR
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents€15,038€20,154€31,150€24,280
Short-Term Investments€0€66€0€0
Receivables€18,233€1,514€7,298€5,164
Inventory€89€64€179€190
Other Curr. Assets€2,212€5,845€2,019€2,360
Total Curr. Assets€35,572€27,643€40,646€31,994
Property Plant & Equip (Net)€7,910€8,603€8,522€9,172
Goodwill€0€0€0€0
Intangibles€2,854€1,769€1,317€1,343
Long-Term Investments€542€486€200€0
Tax Assets€0€0€0-€1,343
Other NC Assets€2,000€0€238€1,765
Total NC Assets€13,306€10,858€10,277€10,937
Other Assets€0€0€0€0
Total Assets€48,878€38,501€50,923€42,931
Liabilities
Payables€10,169€8,827€5,704€6,349
Short-Term Debt€2,547€3,127€7,107€3,398
Tax Payable€0€92€78€57
Deferred Revenue€0€0€0€57
Other Curr. Liab.€3,328€2,515€1,832€1,718
Total Curr. Liab.€16,044€14,561€14,721€11,522
LT Debt€11,858€12,831€10,063€10,620
Deferred Rev, NC€0€0€0€0
Deferred Tax Liab, NC€0€0€0€0
Other NC Liab.€12,681€773€527€323
Total NC Liab.€24,539€13,604€10,590€10,943
Other Liabilities€0€0€1€0
Cap. Leases€5,519€6,000€4,739€5,138
Total Liabilities€40,583€28,165€25,312€22,465
Equity
Pref Stock€0€0€0€0
Common Stock€1,614€1,398€1,392€1,162
Retained Earnings-€13,430-€26,304-€10,976-€17,857
AOCI€0€0-€1€0
Other Equity€20,111€35,242€35,196€37,161
Total Equity€8,295€10,336€25,611€20,466
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€48,878€38,501€50,923€42,931
Net Debt-€633-€4,196-€13,980-€10,262